Dr. Chew graduated with a PhD in immunology from Agency of Science, Technology and Research (A*STAR) Graduate Scholarship program in Singapore. She then started her postdoctoral training in Singapore Immunology Network (SIgN), A*STAR focusing on tumor immunology. Since 2015, Dr Chew joined Translational Immunology Institute (TII), SingHealth Duke-NUS to advance her professional career in tumor immunology research. She also holds assistant professor position with Duke-NUS Medical School.
Dr Chew is the key researcher leading the project on understanding the impact of tumor immune microenvironment on clinical outcome in patients with hepatocellular carcinoma (HCC). Her work has gained recognition with multiple grant awards and high impact journals including Gut, JNCI, PNAS, and Journal of Hepatology. Dr Chew is also one of the key investigators in Precision Medicine in Liver Cancer Asia-Pacific Network (PLANET) funded by NMRC, Singapore. Her team was also awarded Outstanding Early Career Investigator Team (Cancer) by the Interstellar Initiative program from New York Academy of Sciences in 2017.